Traditional Chinese medicine and cancer: History, present situation, and development

被引：160
作者：
Liu, Jie [1 ]
Wang, Shuo [1 ,2 ]
Zhang, Ying [1 ]
Fan, Hui-ting [1 ]
Lin, Hong-sheng [1 ]
机构：
[1] China Acad Chinese Med Sci, Guanganmen Hosp, Dept Oncol, Beijing 100053, Peoples R China
[2] Beijing Univ Chinese Med, Guanganmen Hosp, Clin Med Coll, Beijing, Peoples R China
来源：
THORACIC CANCER | 2015年 / 6卷 / 05期
关键词：
Cancer; development; history; present situation; traditional Chinese medicine; CELL LUNG-CANCER; SIGNALING PATHWAYS; HERBAL MEDICINE; GASTRIC-CANCER; BREAST-CANCER; IMMUNOMODULATORY ACTIVITIES; INTEGRATIVE ONCOLOGY; ADJUNCTIVE THERAPY; ARSENIC TRIOXIDE; METAANALYSIS;
D O I：
10.1111/1759-7714.12270
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Cancer treatment with traditional Chinese medicine (TCM) has a long history. Heritage provides general conditions for the innovation and development of TCM in oncology. This article reviews the development of TCM in oncology, interprets the position and function of TCM for cancer prevention and treatment, summarizes the innovations of TCM in oncology over nearly fifty years, and suggests the development direction.
引用
收藏
页码：561 / 569
页数：9
相关论文
共 79 条
  • [1] [Anonymous], 1995, Tradit Chin Med
  • [2] [Anonymous], 2008, World Sci Technol
  • [3] [Anonymous], TCM RES
  • [4] Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis
    Aoyama, Toru
    Nishikawa, Kazuhiro
    Takiguchi, Nobuhiro
    Tanabe, Kazuaki
    Imano, Motohiro
    Fukushima, Ryoji
    Sakamoto, Junichi
    Oba, Mari S.
    Morita, Satoshi
    Kono, Toru
    Tsuburaya, Akira
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (05) : 1047 - 1054
  • [5] Computational analysis of image-based drug profiling predicts synergistic drug combinations: Applications in triple-negative breast cancer
    Brandl, Miriam B.
    Pasquier, Eddy
    Li, Fuhai
    Beck, Dominik
    Zhang, Sufang
    Zhao, Hong
    Kavallaris, Maria
    Wong, Stephen T. C.
    [J]. MOLECULAR ONCOLOGY, 2014, 8 (08) : 1548 - 1560
  • [6] Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking
    Chen, X
    Murakami, T
    Oppenheim, JJ
    Howard, OMZ
    [J]. BLOOD, 2005, 106 (07) : 2409 - 2416
  • [7] Chinese Academy of Medical Sciences (CAMS), 2010, TCM GUID EV BAS CLIN
  • [8] In vitro and in vivo anti-tumor effects of Astragalus membranaceus
    Cho, William C. S.
    Leung, Kwok N.
    [J]. CANCER LETTERS, 2007, 252 (01) : 43 - 54
  • [9] Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway
    Dong, Yanmin
    Lu, Binbin
    Zhang, Xiaoli
    Zhang, Jing
    Lai, Li
    Li, Dali
    Wu, Yuanyuan
    Song, Yajuan
    Luo, Jian
    Pang, Xiufeng
    Yi, Zhengfang
    Liu, Mingyao
    [J]. CARCINOGENESIS, 2010, 31 (12) : 2097 - 2104
  • [10] Fan Chun-xiang, 2010, Zhonghua Zhong Liu Za Zhi, V32, P294
12345678